aluates Reports

$ 0.0

Automative

Global Hereditary Angioedema Treatment Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-2R7670

Global Hereditary Angioedema Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Hereditary Angioedema Treatment Market Research Report 2025

Code: QYRE-Auto-2R7670

Report

July 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CSL Limited

Pharming Group

Shire plc (Takeda Pharmaceutical Company Limited)

Ionis Pharmaceuticals

Attune Pharmaceuticals

BioCryst Pharmaceuticals

KalVista Pharmaceuticals

Hereditary Angioedema Treatment Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Hereditary Angioedema Treatment Market

The global market for Hereditary Angioedema Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hereditary Angioedema Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Angioedema Treatment.

The Hereditary Angioedema Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hereditary Angioedema Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hereditary Angioedema Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hereditary Angioedema Treatment Market Report

Report Metric	Details
Report Name	Hereditary Angioedema Treatment Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Selective Bradykinin B2 Receptor Antagonists (Firazyr) Kallikrein Inhibitors (Kalbitor, Takhzyro) Others (Conventional Drugs, Pipeline Drugs)
Segment by Application	Hospital Pharmacies Retail Pharmacies Others (online pharmacies, mail pharmacies)
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CSL, Pharming Group, Shire plc (Takeda Pharmaceutical Company Limited), Ionis Pharmaceuticals, Attune Pharmaceuticals, BioCryst Pharmaceuticals, KalVista Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hereditary Angioedema Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hereditary Angioedema Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hereditary Angioedema Treatment Market report?

Ans: The main players in the Hereditary Angioedema Treatment Market are CSL, Pharming Group, Shire plc (Takeda Pharmaceutical Company Limited), Ionis Pharmaceuticals, Attune Pharmaceuticals, BioCryst Pharmaceuticals, KalVista Pharmaceuticals

What are the Application segmentation covered in the Hereditary Angioedema Treatment Market report?

Ans: The Applications covered in the Hereditary Angioedema Treatment Market report are Hospital Pharmacies, Retail Pharmacies, Others (online pharmacies, mail pharmacies)

What are the Type segmentation covered in the Hereditary Angioedema Treatment Market report?

Ans: The Types covered in the Hereditary Angioedema Treatment Market report are C1 Estearse Inhibitors (Plasma Products, Recombinant Products), Selective Bradykinin B2 Receptor Antagonists (Firazyr), Kallikrein Inhibitors (Kalbitor, Takhzyro), Others (Conventional Drugs, Pipeline Drugs)

Recommended Reports

Medical Devices

Disease Treatments

Oral & Pediatric Care

1 Hereditary Angioedema Treatment Market Overview

1.1 Product Definition

1.2 Hereditary Angioedema Treatment by Type

1.2.1 Global Hereditary Angioedema Treatment Market Value Comparison by Type (2024 VS 2031)

1.2.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)

1.2.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr)

1.2.4 Kallikrein Inhibitors (Kalbitor, Takhzyro)

1.2.5 Others (Conventional Drugs, Pipeline Drugs)

1.3 Hereditary Angioedema Treatment by Application

1.3.1 Global Hereditary Angioedema Treatment Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Others (online pharmacies, mail pharmacies)

1.4 Global Hereditary Angioedema Treatment Market Size Estimates and Forecasts

1.4.1 Global Hereditary Angioedema Treatment Revenue 2020-2031

1.4.2 Global Hereditary Angioedema Treatment Sales 2020-2031

1.4.3 Global Hereditary Angioedema Treatment Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Hereditary Angioedema Treatment Market Competition by Manufacturers

2.1 Global Hereditary Angioedema Treatment Sales Market Share by Manufacturers (2020-2025)

2.2 Global Hereditary Angioedema Treatment Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Hereditary Angioedema Treatment Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Hereditary Angioedema Treatment, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Hereditary Angioedema Treatment, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Hereditary Angioedema Treatment, Product Type & Application

2.7 Global Key Manufacturers of Hereditary Angioedema Treatment, Date of Enter into This Industry

2.8 Global Hereditary Angioedema Treatment Market Competitive Situation and Trends

2.8.1 Global Hereditary Angioedema Treatment Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Hereditary Angioedema Treatment Players Market Share by Revenue

2.8.3 Global Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Hereditary Angioedema Treatment Market Scenario by Region

3.1 Global Hereditary Angioedema Treatment Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Hereditary Angioedema Treatment Sales by Region: 2020-2031

3.2.1 Global Hereditary Angioedema Treatment Sales by Region: 2020-2025

3.2.2 Global Hereditary Angioedema Treatment Sales by Region: 2026-2031

3.3 Global Hereditary Angioedema Treatment Revenue by Region: 2020-2031

3.3.1 Global Hereditary Angioedema Treatment Revenue by Region: 2020-2025

3.3.2 Global Hereditary Angioedema Treatment Revenue by Region: 2026-2031

3.4 North America Hereditary Angioedema Treatment Market Facts & Figures by Country

3.4.1 North America Hereditary Angioedema Treatment Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Hereditary Angioedema Treatment Sales by Country (2020-2031)

3.4.3 North America Hereditary Angioedema Treatment Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Hereditary Angioedema Treatment Market Facts & Figures by Country

3.5.1 Europe Hereditary Angioedema Treatment Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Hereditary Angioedema Treatment Sales by Country (2020-2031)

3.5.3 Europe Hereditary Angioedema Treatment Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Hereditary Angioedema Treatment Market Facts & Figures by Region

3.6.1 Asia Pacific Hereditary Angioedema Treatment Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Hereditary Angioedema Treatment Sales by Region (2020-2031)

3.6.3 Asia Pacific Hereditary Angioedema Treatment Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Hereditary Angioedema Treatment Market Facts & Figures by Country

3.7.1 Latin America Hereditary Angioedema Treatment Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Hereditary Angioedema Treatment Sales by Country (2020-2031)

3.7.3 Latin America Hereditary Angioedema Treatment Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Hereditary Angioedema Treatment Market Facts & Figures by Country

3.8.1 Middle East and Africa Hereditary Angioedema Treatment Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Hereditary Angioedema Treatment Sales by Country (2020-2031)

3.8.3 Middle East and Africa Hereditary Angioedema Treatment Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Hereditary Angioedema Treatment Sales by Type (2020-2031)

4.1.1 Global Hereditary Angioedema Treatment Sales by Type (2020-2025)

4.1.2 Global Hereditary Angioedema Treatment Sales by Type (2026-2031)

4.1.3 Global Hereditary Angioedema Treatment Sales Market Share by Type (2020-2031)

4.2 Global Hereditary Angioedema Treatment Revenue by Type (2020-2031)

4.2.1 Global Hereditary Angioedema Treatment Revenue by Type (2020-2025)

4.2.2 Global Hereditary Angioedema Treatment Revenue by Type (2026-2031)

4.2.3 Global Hereditary Angioedema Treatment Revenue Market Share by Type (2020-2031)

4.3 Global Hereditary Angioedema Treatment Price by Type (2020-2031)

5 Segment by Application

5.1 Global Hereditary Angioedema Treatment Sales by Application (2020-2031)

5.1.1 Global Hereditary Angioedema Treatment Sales by Application (2020-2025)

5.1.2 Global Hereditary Angioedema Treatment Sales by Application (2026-2031)

5.1.3 Global Hereditary Angioedema Treatment Sales Market Share by Application (2020-2031)

5.2 Global Hereditary Angioedema Treatment Revenue by Application (2020-2031)

5.2.1 Global Hereditary Angioedema Treatment Revenue by Application (2020-2025)

5.2.2 Global Hereditary Angioedema Treatment Revenue by Application (2026-2031)

5.2.3 Global Hereditary Angioedema Treatment Revenue Market Share by Application (2020-2031)

5.3 Global Hereditary Angioedema Treatment Price by Application (2020-2031)

6 Key Companies Profiled

6.1 CSL

6.1.1 CSL Company Information

6.1.2 CSL Description and Business Overview

6.1.3 CSL Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2020-2025)

6.1.4 CSL Hereditary Angioedema Treatment Product Portfolio

6.1.5 CSL Recent Developments/Updates

6.2 Pharming Group

6.2.1 Pharming Group Company Information

6.2.2 Pharming Group Description and Business Overview

6.2.3 Pharming Group Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pharming Group Hereditary Angioedema Treatment Product Portfolio

6.2.5 Pharming Group Recent Developments/Updates

6.3 Shire plc (Takeda Pharmaceutical Company Limited)

6.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Company Information

6.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Description and Business Overview

6.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Portfolio

6.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Developments/Updates

6.4 Ionis Pharmaceuticals

6.4.1 Ionis Pharmaceuticals Company Information

6.4.2 Ionis Pharmaceuticals Description and Business Overview

6.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Portfolio

6.4.5 Ionis Pharmaceuticals Recent Developments/Updates

6.5 Attune Pharmaceuticals

6.5.1 Attune Pharmaceuticals Company Information

6.5.2 Attune Pharmaceuticals Description and Business Overview

6.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Product Portfolio

6.5.5 Attune Pharmaceuticals Recent Developments/Updates

6.6 BioCryst Pharmaceuticals

6.6.1 BioCryst Pharmaceuticals Company Information

6.6.2 BioCryst Pharmaceuticals Description and Business Overview

6.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2020-2025)

6.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Portfolio

6.6.5 BioCryst Pharmaceuticals Recent Developments/Updates

6.7 KalVista Pharmaceuticals

6.7.1 KalVista Pharmaceuticals Company Information

6.7.2 KalVista Pharmaceuticals Description and Business Overview

6.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2020-2025)

6.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Portfolio

6.7.5 KalVista Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Hereditary Angioedema Treatment Industry Chain Analysis

7.2 Hereditary Angioedema Treatment Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Hereditary Angioedema Treatment Production Mode & Process Analysis

7.4 Hereditary Angioedema Treatment Sales and Marketing

7.4.1 Hereditary Angioedema Treatment Sales Channels

7.4.2 Hereditary Angioedema Treatment Distributors

7.5 Hereditary Angioedema Treatment Customer Analysis

8 Hereditary Angioedema Treatment Market Dynamics

8.1 Hereditary Angioedema Treatment Industry Trends

8.2 Hereditary Angioedema Treatment Market Drivers

8.3 Hereditary Angioedema Treatment Market Challenges

8.4 Hereditary Angioedema Treatment Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

CSL Limited

Pharming Group

Shire plc (Takeda Pharmaceutical Company Limited)

Ionis Pharmaceuticals

Attune Pharmaceuticals

BioCryst Pharmaceuticals

KalVista Pharmaceuticals

List of Tables

Table 1. Global Hereditary Angioedema Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Hereditary Angioedema Treatment Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Hereditary Angioedema Treatment Market Competitive Situation by Manufacturers in 2024

Table 4. Global Hereditary Angioedema Treatment Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Hereditary Angioedema Treatment Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Hereditary Angioedema Treatment Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Hereditary Angioedema Treatment Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Hereditary Angioedema Treatment Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Hereditary Angioedema Treatment, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Hereditary Angioedema Treatment, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Hereditary Angioedema Treatment, Product Type & Application

Table 12. Global Key Manufacturers of Hereditary Angioedema Treatment, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Hereditary Angioedema Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Treatment as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Hereditary Angioedema Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Hereditary Angioedema Treatment Sales by Region (2020-2025) & (K Units)

Table 18. Global Hereditary Angioedema Treatment Sales Market Share by Region (2020-2025)

Table 19. Global Hereditary Angioedema Treatment Sales by Region (2026-2031) & (K Units)

Table 20. Global Hereditary Angioedema Treatment Sales Market Share by Region (2026-2031)

Table 21. Global Hereditary Angioedema Treatment Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Hereditary Angioedema Treatment Revenue Market Share by Region (2020-2025)

Table 23. Global Hereditary Angioedema Treatment Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Hereditary Angioedema Treatment Revenue Market Share by Region (2026-2031)

Table 25. North America Hereditary Angioedema Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Hereditary Angioedema Treatment Sales by Country (2020-2025) & (K Units)

Table 27. North America Hereditary Angioedema Treatment Sales by Country (2026-2031) & (K Units)

Table 28. North America Hereditary Angioedema Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Hereditary Angioedema Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Hereditary Angioedema Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Hereditary Angioedema Treatment Sales by Country (2020-2025) & (K Units)

Table 32. Europe Hereditary Angioedema Treatment Sales by Country (2026-2031) & (K Units)

Table 33. Europe Hereditary Angioedema Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Hereditary Angioedema Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Hereditary Angioedema Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Hereditary Angioedema Treatment Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Hereditary Angioedema Treatment Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Hereditary Angioedema Treatment Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Hereditary Angioedema Treatment Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Hereditary Angioedema Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Hereditary Angioedema Treatment Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Hereditary Angioedema Treatment Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Hereditary Angioedema Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Hereditary Angioedema Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Hereditary Angioedema Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Hereditary Angioedema Treatment Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Hereditary Angioedema Treatment Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Hereditary Angioedema Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Hereditary Angioedema Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Hereditary Angioedema Treatment Sales (K Units) by Type (2020-2025)

Table 51. Global Hereditary Angioedema Treatment Sales (K Units) by Type (2026-2031)

Table 52. Global Hereditary Angioedema Treatment Sales Market Share by Type (2020-2025)

Table 53. Global Hereditary Angioedema Treatment Sales Market Share by Type (2026-2031)

Table 54. Global Hereditary Angioedema Treatment Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Hereditary Angioedema Treatment Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Hereditary Angioedema Treatment Revenue Market Share by Type (2020-2025)

Table 57. Global Hereditary Angioedema Treatment Revenue Market Share by Type (2026-2031)

Table 58. Global Hereditary Angioedema Treatment Price (USD/Unit) by Type (2020-2025)

Table 59. Global Hereditary Angioedema Treatment Price (USD/Unit) by Type (2026-2031)

Table 60. Global Hereditary Angioedema Treatment Sales (K Units) by Application (2020-2025)

Table 61. Global Hereditary Angioedema Treatment Sales (K Units) by Application (2026-2031)

Table 62. Global Hereditary Angioedema Treatment Sales Market Share by Application (2020-2025)

Table 63. Global Hereditary Angioedema Treatment Sales Market Share by Application (2026-2031)

Table 64. Global Hereditary Angioedema Treatment Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Hereditary Angioedema Treatment Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Hereditary Angioedema Treatment Revenue Market Share by Application (2020-2025)

Table 67. Global Hereditary Angioedema Treatment Revenue Market Share by Application (2026-2031)

Table 68. Global Hereditary Angioedema Treatment Price (USD/Unit) by Application (2020-2025)

Table 69. Global Hereditary Angioedema Treatment Price (USD/Unit) by Application (2026-2031)

Table 70. CSL Company Information

Table 71. CSL Description and Business Overview

Table 72. CSL Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. CSL Hereditary Angioedema Treatment Product

Table 74. CSL Recent Developments/Updates

Table 75. Pharming Group Company Information

Table 76. Pharming Group Description and Business Overview

Table 77. Pharming Group Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Pharming Group Hereditary Angioedema Treatment Product

Table 79. Pharming Group Recent Developments/Updates

Table 80. Shire plc (Takeda Pharmaceutical Company Limited) Company Information

Table 81. Shire plc (Takeda Pharmaceutical Company Limited) Description and Business Overview

Table 82. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product

Table 84. Shire plc (Takeda Pharmaceutical Company Limited) Recent Developments/Updates

Table 85. Ionis Pharmaceuticals Company Information

Table 86. Ionis Pharmaceuticals Description and Business Overview

Table 87. Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Ionis Pharmaceuticals Hereditary Angioedema Treatment Product

Table 89. Ionis Pharmaceuticals Recent Developments/Updates

Table 90. Attune Pharmaceuticals Company Information

Table 91. Attune Pharmaceuticals Description and Business Overview

Table 92. Attune Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Attune Pharmaceuticals Hereditary Angioedema Treatment Product

Table 94. Attune Pharmaceuticals Recent Developments/Updates

Table 95. BioCryst Pharmaceuticals Company Information

Table 96. BioCryst Pharmaceuticals Description and Business Overview

Table 97. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product

Table 99. BioCryst Pharmaceuticals Recent Developments/Updates

Table 100. KalVista Pharmaceuticals Company Information

Table 101. KalVista Pharmaceuticals Description and Business Overview

Table 102. KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. KalVista Pharmaceuticals Hereditary Angioedema Treatment Product

Table 104. KalVista Pharmaceuticals Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Hereditary Angioedema Treatment Distributors List

Table 108. Hereditary Angioedema Treatment Customers List

Table 109. Hereditary Angioedema Treatment Market Trends

Table 110. Hereditary Angioedema Treatment Market Drivers

Table 111. Hereditary Angioedema Treatment Market Challenges

Table 112. Hereditary Angioedema Treatment Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Hereditary Angioedema Treatment

Figure 2. Global Hereditary Angioedema Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Hereditary Angioedema Treatment Market Share by Type: 2024 & 2031

Figure 4. C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Product Picture

Figure 5. Selective Bradykinin B2 Receptor Antagonists (Firazyr) Product Picture

Figure 6. Kallikrein Inhibitors (Kalbitor, Takhzyro) Product Picture

Figure 7. Others (Conventional Drugs, Pipeline Drugs) Product Picture

Figure 8. Global Hereditary Angioedema Treatment Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Hereditary Angioedema Treatment Market Share by Application: 2024 & 2031

Figure 10. Hospital Pharmacies

Figure 11. Retail Pharmacies

Figure 12. Others (online pharmacies, mail pharmacies)

Figure 13. Global Hereditary Angioedema Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Hereditary Angioedema Treatment Market Size (2020-2031) & (US$ Million)

Figure 15. Global Hereditary Angioedema Treatment Sales (2020-2031) & (K Units)

Figure 16. Global Hereditary Angioedema Treatment Average Price (USD/Unit) & (2020-2031)

Figure 17. Hereditary Angioedema Treatment Report Years Considered

Figure 18. Hereditary Angioedema Treatment Sales Share by Manufacturers in 2024

Figure 19. Global Hereditary Angioedema Treatment Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Hereditary Angioedema Treatment Players: Market Share by Revenue in Hereditary Angioedema Treatment in 2024

Figure 21. Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Hereditary Angioedema Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Hereditary Angioedema Treatment Sales Market Share by Country (2020-2031)

Figure 24. North America Hereditary Angioedema Treatment Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Hereditary Angioedema Treatment Sales Market Share by Country (2020-2031)

Figure 28. Europe Hereditary Angioedema Treatment Revenue Market Share by Country (2020-2031)

Figure 29. Germany Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Hereditary Angioedema Treatment Revenue Market Share by Region (2020-2031)

Figure 36. China Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Hereditary Angioedema Treatment Sales Market Share by Country (2020-2031)

Figure 47. Latin America Hereditary Angioedema Treatment Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Hereditary Angioedema Treatment Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Hereditary Angioedema Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Hereditary Angioedema Treatment by Type (2020-2031)

Figure 57. Global Revenue Market Share of Hereditary Angioedema Treatment by Type (2020-2031)

Figure 58. Global Hereditary Angioedema Treatment Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Hereditary Angioedema Treatment by Application (2020-2031)

Figure 60. Global Revenue Market Share of Hereditary Angioedema Treatment by Application (2020-2031)

Figure 61. Global Hereditary Angioedema Treatment Price (USD/Unit) by Application (2020-2031)

Figure 62. Hereditary Angioedema Treatment Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Potential Therapy Equipment Market Insights Forecast to 2030

Global Medical Cosmetology Product Market Insights Forecast to 2030

Personalized Medical Care Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Genomic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Thrombin Human Market Research Report 2025

Precision Medicine Solution Market

Angiocatheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Angiographic Interventional Therapy System Market Research Report 2025

Global Vascular Interventional Apparatus Market Insights Forecast to 2030

Global Medical Gold Colloids Market Insights Forecast to 2030

Global Vessel Sealing Market Insights Forecast to 2030

Global Automatic Hematology Analyzers Market Insights Forecast to 2030

Global Medical Health Scale Market Insights Forecast to 2030

Absorbable Sealing Medical Glue Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hereditary Angioedema Therapeutic Market Insights Forecast to 2030

Global Natural Language Processing in Healthcare Market Research Report 2025

Hereditary Amyloidosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

HA Facial Filler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Angio Seal Devices Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions